C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C07K 16/00 (2006.01) G01N 33/50 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2471570
The present invention concerns methods for identifying candidate sequences for antibody specific against an antigen produced by a micro-organism during an infection or against a vaccine, methods of manufacture of medicaments, and methods of treatment of patients using same. Also provided is a method for determining the efficacy of a vaccine, together with methods of vaccinating a patient.
L'invention concerne des procédés d'identification de séquences candidates pour un anticorps spécifique contre un antigène produit par un micro-organisme pendant une infection ou contre un vaccin; des procédés de production de médicaments; et des procédés de traitement de patients faisant appel aux procédés précités. L'invention concerne également un procédé permettant de déterminer l'efficacité d'un vaccin, associé à des procédés de vaccination d'un patient.
Burnie James Peter
Matthews Ruth Christine
Rigg Gordon Patrick
Williamson Peter
Neutec Pharma Plc
Oyen Wiggs Green & Mutala Llp
LandOfFree
Focussed antibody technology does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Focussed antibody technology, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Focussed antibody technology will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1818010